Hand-picked stories from across the web, curated for relevance and quality.
Titan Partners has appointed three senior analysts with over 40 years of combined experience to expand its equity research platform across technology, healthcare, and energy sectors, strengthening its focus on underfollowed small- and mid-cap public companies.
Read full story
The NHS in England is rolling out a new subcutaneous injection of pembrolizumab, reducing administration time from hours to minutes, improving patient convenience and healthcare efficiency.
Read full story
Stonegate Capital Partners highlights OS Therapies' progress toward late-stage regulatory milestones, including EMA rolling review and TGA endpoint alignment, with dense 2026 catalysts centered on survival data.
Read full story
AI Maverick Intel issued 76.5 million shares to HEAL Group as an initial tranche for acquiring HEAL Access Canada, with total consideration adjusted to 100 million shares, and plans to uplist to OTCQB.
Read full story
The company's step-back drill hole aims to assess phosphate grade continuity at depth, with minor technical issues being resolved by the drilling contractor.
Read full story
LaFleur Minerals announced wide gold intercepts from its drilling program at the Swanson Gold Project, confirming mineralization continuity and supporting expansion beyond current resource and open-pit limits, which strengthens the project's development prospects tied to a planned mill restart.
Read full story
Bullish (NYSE: BLSH) acquires Equiniti for $4.2 billion to combine its digital asset platform with Equiniti's regulated transfer agent services, aiming to create a global platform for tokenized securities as capital markets shift to blockchain.
Read full story
SPARC AI Inc. was highlighted in an AINewsWire editorial discussing how software-driven autonomy is transforming drone warfare, emphasizing the company's GPS-denied navigation platform.
Read full story
HR.com announces winners of the 2026 Employee Well-being Awards, recognizing Avidon Health for its accessible behavior change platform and Hancock Health for a comprehensive weight management program, highlighting a shift toward scalable, evidence-based wellness initiatives.
Read full story
Lunai Bioworks has filed a federal lawsuit in Delaware accusing unidentified naked short sellers of manipulating its stock, with failures to deliver shares reaching 234.6 times the maximum baseline daily rate and trading volumes exceeding the company's outstanding shares by over 15 times.
Read full story
MindBio Therapeutics is developing an AI-driven voice analysis platform for real-time intoxication detection, with implications for law enforcement, workplace safety, and healthcare.
Read full story
Oncotelic Therapeutics' intranasal nose-to-brain delivery platform is highlighted as a key innovation in overcoming the blood-brain barrier, opening opportunities in neurological disease and biodefense.
Read full storySPARC AI Inc. is featured in an AINewsWire editorial discussing how software-driven autonomy is transforming drone warfare, highlighting the company's GPS-denied navigation and targeting solution as a cost-effective alternative to hardware-heavy approaches.
Read full story
Viemed Healthcare's first-quarter results demonstrate improving growth quality with stronger free cash flow conversion and a diversifying revenue mix, reducing reliance on legacy ventilation.
Read full story
MindBio Therapeutics CEO Justin Hanka appeared on the TechMediaWire Podcast to discuss the company’s AI-driven voice analysis technology for detecting drug and alcohol intoxication, which aims to improve safety in regulated workplaces such as mining.
Read full story
SureNano Science Ltd. is featured in a BioMedWire editorial highlighting its subsidiary GlucaPharm's GEP-44, a novel triple agonist peptide aiming to improve efficacy, tolerability, and delivery flexibility in the expanding GLP-1 market for obesity and type 2 diabetes.
Read full story
Tonix Pharmaceuticals reported Q1 2026 financial results, emphasizing the commercial growth of its recently launched fibromyalgia treatment TONMYA and advancement of its pipeline, including positive Phase 1 data for a Lyme disease prevention candidate.
Read full story
Lantern Pharma will report first-quarter 2026 results on May 15, providing updates on clinical trials and its AI platform, which is important for investors tracking the company's progress in precision oncology.
Read full story
Premier Graphene Inc. completed its first military order for Mexico's SEDENA, positioning the company for expanded graphene-enhanced defense supply opportunities across Latin America.
Read full story
Qdrant's vector search technology enables Sapu's AI platform to index and query all 28 million PubMed abstracts, accelerating cancer research and biomedical discovery.
Read full story
Greene Concepts Inc. reports that its Be Water brand is receiving positive customer reviews on Walmart.com, highlighting its smooth taste and natural sourcing, which underscores growing consumer awareness of water quality.
Read full story
VectorCertain's SecureAgent governance platform blocked 100% of 837 attack scenarios across seven sub-categories of Anthropic's T7 Capability Proliferation, proving pre-execution AI governance can stop self-replicating and swarm-coordinating agents before they execute.
Read full story
American Shared Hospital Services (NYSE American: AMS) will release its Q1 2026 financial results on May 14, 2026, and hold a conference call at 12:00 PM ET to discuss performance and outlook.
Read full story
FastBlast promotes its plant-based, convenient nutrition products to support consistent wellness habits during seasonal transitions, emphasizing sustainability over restrictive diets.
Read full story
Santos Muscle Nutrition, a Dutch sports nutrition brand, plans to launch its products on Amazon as part of its strategy to enter the U.S. market, leveraging the platform's reach to increase accessibility for athletes and fitness consumers.
Read full storyAuddia Inc. showcases Influence Healthcare, an AI-driven platform that empowers surgeons to lead value-based care in high-spend specialties, as it prepares to file its S-4 registration for a merger that will create McCarthy Finney.
Read full story
Italian wellness company DuLac Farmaceutici announces plans to expand its U.S. presence beyond Amazon, leveraging pharmaceutical heritage and vertically integrated production to meet growing demand for recovery-focused dermocosmetic products.
Read full story
ORGANA International's Genuine Essiac Tea, available on Amazon, receives strong customer reviews highlighting its authentic 4-herb formulation and convenience, reflecting growing consumer interest in traditional herbal wellness products.
Read full storyAemetis achieved $54.6 million in Q1 2026 revenues, a 27% year-over-year increase, with positive gross profit of $2.8 million driven by higher Dairy RNG production, LCFS credits, and Section 45Z tax credits, signaling improved operational efficiency and growth across its renewable fuel segments.
Read full storyAclarion announced the inclusion of Lanman Spinal Neurosurgery in its CLARITY trial, marking the first private practice site, which aims to demonstrate Nociscan's ability to improve surgical outcomes for chronic low back pain and expedite enrollment.
Read full story